Evidence map›Paper›PMID 10880413›Full record

ArticleCirculation2000

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

A Festa, R D'Agostino, G Howard, L Mykkänen, R P Tracy, S M Haffner

3 registry-linked trialsAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Circulation, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 629 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
629citing papers in PubMed, 9 pooled it
64.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01524705 phase4completedstarted 2012, after this paper: background citation

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR

Ran2012Enrolled102Registered outcomes4Posted comparisons3ConditionsType 2 DiabetesArmsexenatide, Insulin glargine, Metformin, Prandial insulin
Open the trial in the graph
NCT00005135 completednot on this map

Insulin Resistance Atherosclerosis Study (IRAS)

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran1991 to 2008ConditionsCardiovascular Diseases, Atherosclerosis, Diabetes Mellitus, Heart Diseases
NCT00233311 completednot on this mapstarted 2004, after this paper: background citation

Assessment of the Postprandial Effects of a Fast-food on Inflammatory Markers

TypeobservationalSponsorNational Institute on Aging (NIA)Ran2004 to 2012Enrolled61ConditionsHeart Diseases, Diabetes, Obesity
3 · Its place in the literature

Who cites it

629 citing papers in PubMed, 9 syntheses or guidelines pooled it, 2,358 citations in OpenAlex.

  1. Pooled it
  2. Association between priori and posteriori dietary patterns and gastric cancer risk: an updated systematic review and meta-analysis of observational studies.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Review
  17. Article
  18. Observational
  19. Review
  20. Article

569 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A FestaDepartment of Medicine, University of Texas Health Science Center at San Antonio, 78228-3900, USA. festa@magnet.at
R D'Agostino
G Howard
L Mykkänen
R P Tracy
S M Haffner
The University of Texas Health Science Center at San Antonio · US

Funding

INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047887 · NHLBI · WAKE FOREST UNIVERSITY · PI WAGENKNECHT, LYNNE E · 1991 to 1999
–
INSULIN RESISTANCE, HYPERGLYCEMIA AND ATHEROSCLEROSISU01HL047889 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI SELBY, JOE V · 1991 to 1999
–
INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047890 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMAN, RICHARD N. · 1991 to 1999
–
NHLBI NIH HHS HL-47887NHLBI NIH HHS HL-47889NHLBI NIH HHS HL-47890
6 · The paper itself

Abstract

backgroundInflammation has been suggested as a risk factor for the development of atherosclerosis. Recently, some components of the insulin resistance syndrome (IRS) have been related to inflammatory markers. We hypothesized that insulin insensitivity, as directly measured, may be associated with inflammation in nondiabetic subjects. METHODS AND

resultsWe studied the relation of C-reactive protein (CRP), fibrinogen, and white cell count to components of IRS in the nondiabetic population of the Insulin Resistance Atherosclerosis Study (IRAS) (n=1008; age, 40 to 69 years; 33% with impaired glucose tolerance), a multicenter, population-based study. None of the subjects had clinical coronary artery disease. Insulin sensitivity (S(I)) was measured by a frequently sampled intravenous glucose tolerance test, and CRP was measured by a highly sensitive competitive immunoassay. All 3 inflammatory markers were correlated with several components of the IRS. Strong associations were found between CRP and measures of body fat (body mass index, waist circumference), S(I), and fasting insulin and proinsulin (all correlation coefficients >0.3, P<0.0001). The associations were consistent among the 3 ethnic groups of the IRAS. There was a linear increase in CRP levels with an increase in the number of metabolic disorders. Body mass index, systolic blood pressure, and S(I) were related to CRP levels in a multivariate linear regression model.

conclusionsWe suggest that chronic subclinical inflammation is part of IRS. CRP, a predictor of cardiovascular events in previous reports, was independently related to S(I). These findings suggest potential benefits of anti-inflammatory or insulin-sensitizing treatment strategies in healthy individuals with features of IRS.

Indexed as

AdultAgedArteriosclerosisBiomarkersC-Reactive ProteinFemaleFibrinogenHumansInsulin ResistanceLeukocyte CountLinear ModelsMaleMiddle AgedRisk FactorsTriglyceridesBiomarkersC-Reactive ProteinFibrinogenTriglycerides

Identifiers

PMID10880413
OpenAlexW2014663082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.